Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks: WSJ

[April 16, 2021]  (Reuters) - Johnson & Johnson had reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots, but Pfizer Inc and Moderna declined, the Wall Street Journal reported on Friday.

Only AstraZeneca, which had been buffeted by similar blood-clotting concerns for weeks, agreed, the report said, citing people familiar with the matter. (https://on.wsj.com/2Q7E4Ho)

(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)

[© 2021 Thomson Reuters. All rights reserved.]

Copyright 2021 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content